MDT

88.01

+0.07%↑

A

120.5

+2.55%↑

VEEV

158.62

+0.08%↑

HQY

81.13

+1.58%↑

TLRY

6.92

+3.13%↑

MDT

88.01

+0.07%↑

A

120.5

+2.55%↑

VEEV

158.62

+0.08%↑

HQY

81.13

+1.58%↑

TLRY

6.92

+3.13%↑

MDT

88.01

+0.07%↑

A

120.5

+2.55%↑

VEEV

158.62

+0.08%↑

HQY

81.13

+1.58%↑

TLRY

6.92

+3.13%↑

MDT

88.01

+0.07%↑

A

120.5

+2.55%↑

VEEV

158.62

+0.08%↑

HQY

81.13

+1.58%↑

TLRY

6.92

+3.13%↑

MDT

88.01

+0.07%↑

A

120.5

+2.55%↑

VEEV

158.62

+0.08%↑

HQY

81.13

+1.58%↑

TLRY

6.92

+3.13%↑

Search

Quidel Corp

Fermé

17.28 7.46

Résumé

Variation du prix de l'action

24h

Actuel

Min

15.95

Max

17.4

Chiffres clés

By Trading Economics

Revenu

602M

-131M

Ventes

24M

724M

Marge bénéficiaire

-18.062

Employés

6,500

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+71.02% upside

Dividendes

By Dow Jones

Prochains Résultats

6 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-408M

801M

Ouverture précédente

9.82

Clôture précédente

17.28

Quidel Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 avr. 2026, 23:36 UTC

Acquisitions, Fusions, Rachats

China-Backed Yancoal Australia to Buy Kestrel Coal Mine Stake For Up to $2.4 Billion -- Update

14 avr. 2026, 23:24 UTC

Actions en Tendance

Stocks to Watch: Gloo, Broadcom, GitLab

14 avr. 2026, 22:42 UTC

Acquisitions, Fusions, Rachats

China-Backed Yancoal Australia to Buy Kestrel Coal Mine Stake For Up to $2.4 Billion

14 avr. 2026, 21:32 UTC

Principaux Mouvements du Marché

GitLab Shares Rise on Expanded Google Cloud Collaboration

14 avr. 2026, 23:54 UTC

Market Talk

Nikkei May Rise as Fears About Energy Shortage Ease -- Market Talk

14 avr. 2026, 23:34 UTC

Market Talk

Gold Edges Lower on Possible Technical Correction -- Market Talk

14 avr. 2026, 22:54 UTC

Résultats

BRP: Amendment Mainly Leads to 25% Tariff on Total Value of Imported Snowmobiles and Majority of ORV Models, Replacing Previous 50% Tariff on Applicable Metal Content Only >DOO.T

14 avr. 2026, 22:54 UTC

Résultats

BRP: Suspending Guidance Following Amendment of Section 232 Tariffs on Steel, Aluminum and Copper Imports Into U.S., Which Came Into Effect on April 6 >DOO.T

14 avr. 2026, 22:54 UTC

Résultats

BRP: Currently Estimates Potential Incremental Tariff Cost Related to This Amendment in Excess of $500M for Remainder of Yr >DOO.T

14 avr. 2026, 22:54 UTC

Résultats

BRP: Suspends FY27 Guidance Due to Changes to U.S. Tariff Environment

14 avr. 2026, 22:17 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Targets Deal Completion Toward End of 3Q

14 avr. 2026, 22:17 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Acquisition Diversifies Portfolio; Met Coal Share to Rise to 22%

14 avr. 2026, 22:17 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Asset 'Strong Strategic Fit'; to Positively Add Production, Cash Flow

14 avr. 2026, 22:16 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Intends to Fund Acquisition With Cash, 5-Year Loan Facility

14 avr. 2026, 22:15 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Contingent Consideration Linked to Average Annual Prices For 5 Years

14 avr. 2026, 22:14 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Deal Includes Contingent Cash Consideration Up to $550 Million

14 avr. 2026, 22:13 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Deal Includes $1.85 Billion Upfront Consideration

14 avr. 2026, 22:12 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: To Buy Kestrel Stake From EMR Capital, Adaro Capital

14 avr. 2026, 22:12 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: To Buy Kestrel Stake For Up to $2.4 Billion

14 avr. 2026, 22:10 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: to Acquire 80% Interest in Kestrel Coal Mine

14 avr. 2026, 20:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Basic Materials Roundup: Market Talk

14 avr. 2026, 20:33 UTC

Acquisitions, Fusions, Rachats

Microsoft Is Buying 3,200 Acres For a Data Center. This Utility Stock Is Rising. -- Barrons.com

14 avr. 2026, 20:32 UTC

Actions en Tendance

Stocks to Watch: JPMorgan, American Airlines, LVMH, BlackRock -- WSJ

14 avr. 2026, 19:59 UTC

Acquisitions, Fusions, Rachats

Microsoft Is Buying 3,200 Acres For a Data Center. This Utility Stock Is Rising. -- Barrons.com

14 avr. 2026, 19:38 UTC

Résultats

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

14 avr. 2026, 19:27 UTC

Market Talk

U.S. Natural Gas Futures Extend Losing Streak -- Market Talk

14 avr. 2026, 19:21 UTC

Market Talk
Principaux Événements d'Actualité

Oil Futures Retreat on Hopes for U.S.-Iran Peace Talks -- Market Talk

14 avr. 2026, 19:09 UTC

Acquisitions, Fusions, Rachats

Apple and Amazon Partner on Satellite Deal. Why It Makes Sense. -- Barrons.com

14 avr. 2026, 18:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 avr. 2026, 18:30 UTC

Market Talk

Treasury Yields, Dollar Fall as Markets Price Higher Odds of Fed Cuts -- Market Talk

Comparaison

Variation de prix

Quidel Corp prévision

Objectif de Prix

By TipRanks

71.02% hausse

Prévisions sur 12 Mois

Moyen 27.5 USD  71.02%

Haut 38 USD

Bas 17 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

3

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

Bénéfice d'exploitation

$

À Propos Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat